Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantine S Tam

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Leukemia & Lymphoma|June 12, 2012
Allogeneic immunity and anti-CD20 therapy: a potent combination in the treatment of a patient with Richter transformation of chronic lymphocytic leukemiaConstantine S Tam
Hematology. American Society of Hematology. Education Program|December 10, 2021
Upfront therapy: the case for continuous treatmentConstantine S Tam
The Lancet. Haematology|July 5, 2016
Maintenance therapy in CLL: resolving the controversyConstantine S Tam
Clinical Advances in Hematology & Oncology : H&O|March 8, 2019
Zanubrutinib: a novel BTK inhibitor in chronic lymphocytic leukemia and non-Hodgkin lymphomaConstantine S Tam
Leukemia & Lymphoma|September 7, 2012
CARTs to the rescue: therapeutic potential of chimeric antigen receptor T-cells in patients with B-cell malignanciesConstantine S Tam
Leukemia & Lymphoma|August 30, 2008
The rare entity of chronic lymphocytic leukemia in Chinese patients: is it the same disease as in Western patients?Constantine S Tam
Leukemia & Lymphoma|September 17, 2009
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the wayConstantine S Tam
Clinical Advances in Hematology & Oncology : H&O|August 19, 2021
Use of venetoclax combination regimens in chronic lymphocytic leukemiaConstantine S Tam
Leukemia & Lymphoma|September 22, 2015
A novel way to consolidate incomplete responses in chronic lymphocytic leukemia/small lymphocytic lymphomaConstantine S Tam, Aaron Polliack
Current Hematologic Malignancy Reports|April 29, 2010
Nonmyeloablative stem cell transplantation in follicular B-cell lymphomaConstantine S Tam, Issa Khouri
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Leukemia & Lymphoma|June 12, 2012
Allogeneic immunity and anti-CD20 therapy: a potent combination in the treatment of a patient with Richter transformation of chronic lymphocytic leukemiaConstantine S Tam
Hematology. American Society of Hematology. Education Program|December 10, 2021
Upfront therapy: the case for continuous treatmentConstantine S Tam
The Lancet. Haematology|July 5, 2016
Maintenance therapy in CLL: resolving the controversyConstantine S Tam
Clinical Advances in Hematology & Oncology : H&O|March 8, 2019
Zanubrutinib: a novel BTK inhibitor in chronic lymphocytic leukemia and non-Hodgkin lymphomaConstantine S Tam
Leukemia & Lymphoma|September 7, 2012
CARTs to the rescue: therapeutic potential of chimeric antigen receptor T-cells in patients with B-cell malignanciesConstantine S Tam
Leukemia & Lymphoma|August 30, 2008
The rare entity of chronic lymphocytic leukemia in Chinese patients: is it the same disease as in Western patients?Constantine S Tam
Leukemia & Lymphoma|September 17, 2009
Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the wayConstantine S Tam
Clinical Advances in Hematology & Oncology : H&O|August 19, 2021
Use of venetoclax combination regimens in chronic lymphocytic leukemiaConstantine S Tam
Leukemia & Lymphoma|September 22, 2015
A novel way to consolidate incomplete responses in chronic lymphocytic leukemia/small lymphocytic lymphomaConstantine S Tam, Aaron Polliack
Current Hematologic Malignancy Reports|April 29, 2010
Nonmyeloablative stem cell transplantation in follicular B-cell lymphomaConstantine S Tam, Issa Khouri
Pageof 27